Time for a makeover-cosmetics regulation in the United States
© 2019 Wiley Periodicals, Inc..
INTRODUCTION: Cosmetics and personal care products are ubiquitous. Consumer pressure arising from recent episodes of products found to be unsafe has led to new policy proposals to modernize cosmetics regulation in the United States.
METHODS: We reviewed contemporary cosmetics regulation and collected major past and current policy proposals relating to cosmetics regulation with a focus on public health controversies.
RESULTS: Under a structure originally established in 1938 that places regulation of cosmetics under the Food and Drug Administration (FDA), cosmetics manufacturers in the United States are not required to register their products or forward consumer complaints to the FDA, leading to broad under-reporting of adverse events. The FDA has limited authority to mandate product recalls. The existing FDA database system that collects adverse events related to cosmetics has limited public health utility. Current proposals for new cosmetics regulations seek to establish better systems for data collection and mandatory manufacturer registrations funded by cosmetic manufacturers. Additional policy changes could include a premarket review process for cosmeceuticals (cosmetics that make drug-like claims) and more advanced real-world data safety monitoring tools.
CONCLUSIONS: With continued consumer concern and several recent cosmetic-related public health controversies, the FDA should be given more resources and broader authority to protect consumer safety.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Journal of cosmetic dermatology - 18(2019), 6 vom: 03. Dez., Seite 2041-2047 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cornell, Erika M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cosmetic modernization amendments |
|---|
| Anmerkungen: |
Date Completed 04.06.2020 Date Revised 04.06.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/jocd.12886 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM295718447 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM295718447 | ||
| 003 | DE-627 | ||
| 005 | 20231225084251.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jocd.12886 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0985.xml |
| 035 | |a (DE-627)NLM295718447 | ||
| 035 | |a (NLM)30950176 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cornell, Erika M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Time for a makeover-cosmetics regulation in the United States |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.06.2020 | ||
| 500 | |a Date Revised 04.06.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2019 Wiley Periodicals, Inc. | ||
| 520 | |a INTRODUCTION: Cosmetics and personal care products are ubiquitous. Consumer pressure arising from recent episodes of products found to be unsafe has led to new policy proposals to modernize cosmetics regulation in the United States | ||
| 520 | |a METHODS: We reviewed contemporary cosmetics regulation and collected major past and current policy proposals relating to cosmetics regulation with a focus on public health controversies | ||
| 520 | |a RESULTS: Under a structure originally established in 1938 that places regulation of cosmetics under the Food and Drug Administration (FDA), cosmetics manufacturers in the United States are not required to register their products or forward consumer complaints to the FDA, leading to broad under-reporting of adverse events. The FDA has limited authority to mandate product recalls. The existing FDA database system that collects adverse events related to cosmetics has limited public health utility. Current proposals for new cosmetics regulations seek to establish better systems for data collection and mandatory manufacturer registrations funded by cosmetic manufacturers. Additional policy changes could include a premarket review process for cosmeceuticals (cosmetics that make drug-like claims) and more advanced real-world data safety monitoring tools | ||
| 520 | |a CONCLUSIONS: With continued consumer concern and several recent cosmetic-related public health controversies, the FDA should be given more resources and broader authority to protect consumer safety | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cosmetic modernization amendments | |
| 650 | 4 | |a cosmetics regulation | |
| 650 | 4 | |a personal care products | |
| 650 | 4 | |a personal care products safety act | |
| 650 | 7 | |a Cosmetics |2 NLM | |
| 700 | 1 | |a Janetos, Timothy M |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Shuai |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cosmetic dermatology |d 2002 |g 18(2019), 6 vom: 03. Dez., Seite 2041-2047 |w (DE-627)NLM166816639 |x 1473-2165 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2019 |g number:6 |g day:03 |g month:12 |g pages:2041-2047 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jocd.12886 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2019 |e 6 |b 03 |c 12 |h 2041-2047 | ||